Create Alert
Watchlist

Gujarat Themis Biosyn

₹0.00
0.00 (0.00%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All

Performance

Open
0.00
Prev. Close
0.00
Volume
NA
Total traded value
NA
Upper Circuit
NA
Lower Circuit
NA

Fundamentals

Market Cap₹4,044Cr
ROE19.64%
P/E Ratio(TTM)82.85
EPS(TTM)4.48
P/B Ratio16.28
Dividend Yield0.18%
Industry P/E43.26
Book Value22.80
Debt to Equity0.12
Face Value1
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Gujarat Themis Biosyn Ltd

Gujarat Themis Biosyn Limited is an India-based company, which is principally engaged in the manufacturing of pharmaceuticals and medicinal chemical products. The Company is focused on the business of manufacturing and sale of finished active pharmaceutical ingredients (API) products by fermentation process. The Company operates through manufacturing of the bulk drugs segment. Its product portfolio comprises Rifamycin-O and Rifamycin-S. The Company is manufacturing Rifamycin S, which is an intermediate for manufacturing the drug Rifampicin (an Antibiotic used for the treatment of several types of bacterial infections, including tuberculosis, Mycobacterium avium complex, leprosy, and Legionnaires' disease.) and Rifamycin O, which is an intermediate for manufacturing the drug Rifaximin (this is an Antibiotic used for treatment of traveler's diarrhea, irritable bowel syndrome, and hepatic encephalopathy). Its research and development division focuses on developing fermentation cultures.;
Parent OrganisationGujarat Themis Biosyn Ltd
Managing DirectorNA
NSE SymbolGUJTHEM

Shareholding Pattern

Sep '24
Dec '24
Feb '25
Mar '25
Jun '25
Promoters
70.86%
Retail And Others
25.45%
Foreign Institutions
2.51%
Mutual Funds
1.16%
Other Domestic Institutions
0.01%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Divi's Laboratories
NA
(0.00%)
82.08
Jubilant Pharmova
NA
(0.00%)
22.67
Neuland Laboratories
NA
(0.00%)
71.03
Acutaas Chemicals
NA
(0.00%)
62.97